老年早期糖尿病肾病患者血清炎症因子、外周血NFκ-B活性变化及阿托伐他汀的治疗作用  被引量:22

Changes of serum proinflammatory factors and peripheral blood NF-κB activity in elderly diabetics with early nephropathy and treatment effect of Atorvastatin

在线阅读下载全文

作  者:李建英[1] 路文盛[1] 颜晓东[1] 郭进[1] 刘斐[1] 陈健[1] 叶伟林[1] 

机构地区:[1]广西壮族自治区人民医院,南宁530021

出  处:《山东医药》2011年第17期7-9,共3页Shandong Medical Journal

基  金:广西科技厅青年科学基金课题(0991062)

摘  要:目的观察老年早期糖尿病肾病(DN)患者血清炎症因子水平、外周血NF-κB活性的变化,并探讨阿托伐他汀对DN患者的治疗作用。方法根据是否合并DN将96例2型糖尿病患者分为糖尿病(DM)组30例、DN组66例。DN组随机分为DM常规治疗组(DN1组)31例、DM常规治疗+阿托伐他汀治疗组(DN2组)35例,并选择30例健康体检者作为对照组(NC组)。分别观察各组患者高敏C反应蛋白(hs-CRP)、TNF-α、IL-6、IL-1β及外周血NF-κB p65的磷酸化水平。结果 NC组、DM组、DN组血清hs-CRP、TNF-α、IL-6、IL-1β水平及外周血NF-κBp65活性逐渐升高(P<0.01或<0.05)。阿托伐他汀治疗后NF-κB p65活性及hs-CRP、TNF-α、IL-6、IL-1β明显下降(P<0.01或<0.05)。结论阿托伐他汀可抑制老年早期DN患者外周血NF-κB p65的活性,并可降低血清hs-CRP、TNF-α、IL-6、IL-1β等炎症因子的水平,显著改善患者炎症状态。Objective To observe the changes of serum proinflammatory factors and peripheral blood NF-κB activity in elderly diabetics with early nephropathy,and study the treatment effect of Atorvastatin.Methods Ninety-six patients with T2DM,according to whether the merger DN divided into DM group(n=30),DN group(n=66).DN group randomly divided into DM conventional treatment group(DN1 group,n=31),DM conventional therapy + Atorvastatin treatment group(DN2 group,n=35),and choosing 30 cases of healthy check-up persons as control group(NC group).Observing serum proinflammatory factors respectively with hypersensitive C-reactive protein(hs-CRP),TNF-α,IL-6,IL-1β and peripheral blood NF-κB p65 of phosphorylation level.Results In NC group,DM group,DN group,serum proinflammatory factors hs-CRP,TNF-α,IL-6,IL-1β level and peripheral blood NF-κB p65 activity were increasing gradually(P0.01 or0.05).After treatment of Atorvastation,NF-κB p65 activity and proinflammatory factors hs-CRP,TNF-α,IL-6,IL-1β descended obviously(P0.01 or0.05).Conclusions Atorvastatin inhibits peripheral blood NF-κB p65 activity in elderly early DN patients,and could reduce serum proinflammatory factors hs-CRP,TNF-α,IL-6,IL-1β levels,and improve inflammatory condition.

关 键 词:糖尿病 2型 糖尿病肾病 NFΚ-B 炎症趋化因子类 阿托伐他汀 

分 类 号:R587[医药卫生—内分泌] R972[医药卫生—内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象